Trastuzumab with trimodality treatment for oesophageal adenocarcinoma with HER2 overexpression (NRG Oncology/RTOG 1010): a multicentre, randomised, phase 3 trial
Resource Type
Article
Authors
Safran, Howard P ; Winter, Kathryn ; Ilson, David H ; Wigle, Dennis ; DiPetrillo, Thomas ; Haddock, Michael G ; Hong, Theodore S ; Leichman, Lawrence P ; Rajdev, Lakshmi ; Resnick, Murray ; Kachnic, Lisa A ; Seaward, Samantha ; Mamon, Harvey ; Diaz Pardo, Dayssy Alexandra ; Anderson, Carryn M ; Shen, Xinglei ; Sharma, Anand K ; Katz, Alan W ; Salo, Jonathan ; Leonard, Kara L ; Moughan, Jennifer ; Crane, Christopher H
Source
In The Lancet Oncology February 2022 23(2):259-269
Subject
Primary Research Articles
Language
ISSN
1470-2045